Skip to content

Author

Raymond F. Schinazi

We have 5 of 62 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Enabling the Synthesis of the 4'-Thioremdesivir Core.

Nucleosides and nucleoside analogs represent a long established and highly important class of pharmaceutical agents, with numerous U.S. Food and Drug Administration (FDA)-approved examples spanning antiviral, anticancer, and immunological indications. Among these, 4'-thionucleosides-wherein the endocyclic ribose oxygen...

Liu-Qing Wei, M. Kasthuri, Christina G. Na et al. · 0 citations
Open access Oct 2026

4-Diketopyrrole-2-carboxamide derivatives affecting HBV capsid assembly: structure–activity relationship around the GLP-26 scaffold

The structure–activity relationship (SAR) around the 4-diketopyrrole-2-carboxamide scaffold of GLP-26 is discussed, focusing on modifying the aniline moiety and the oxoacetamide region, and introducing alternative acetamide groups.

Zhe Chen, Shao-Man Zhou, Peng Liu et al. · 0 citations
Aug 2026

Human nuclear ribomes reveal DNA-embedded ribonucleotides as epigenetic modulators of transcription-associated DNA supercoiling.

A non-random nuclear "ribome," the genome-wide landscape of embedded rNMPs, enriched in GC-rich regions, regulatory elements, and telomeres, is revealed, revealing a connection between ribonucleotide processing and transcription-associated DNA topology in human cells.

Deepali L. Kundnani, Yeunsook Lee, Taehwan Yang et al. · 0 citations
#protein folding Sep 2026

Integrated AI-Driven Multi-Objective Optimization of Sulfamoylbenzamide-Based HBV Capsid Assembly Modulators: Discovery of 11B-6 with Superior Potency and Drug-like Properties

A multi-objective optimization workflow for the NVR 3-778 is reported by integrating structure-based fragment growing with systematic medicinal chemistry optimization, activity prediction, and multitask prediction of drug-like properties to highlight 11B-6 as a promising next-generation HBV CAM.

Shuo Wang, Miao-Chen Xu, Fei-Yue Ma et al. · 0 citations
Open access Jul 2026

The 5′-Isobutyryl Ester Prodrug of 4′-Thiouridine Inhibits SARS-CoV‑2 Replication in Culture and in a Syrian Hamster Infection Model

iBu TU is highlighted as a promising oral antiviral candidate for treating SARS-CoV-2 infection and significantly reduced viral loads and improved lung health without adverse effects in a Syrian hamster model infected with SARS-CoV-2.

Zhe Chen, F. Amblard, M. Kasthuri et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.